Selected measures of access to and utilization of treatment and prophylaxis for HIV-infected persons

HIV/AIDS Surveillance Supplemental Report, Volume 9, Number 3

A. Antiretroviral Medications
Table 1	HIV-infected patients ever prescribed antiretroviral therapy by data source and sex
Table 2	HIV-infected patients ever prescribed antiretroviral therapy by data source and race/ethnicity
Table 3	HIV-infected patients currently prescribed antiretroviral therapy by data source and insurance status
Table 4	HIV-infected patients currently prescribed antiretroviral therapy by data source and sex
Table 5	HIV-infected patients currently prescribed antiretroviral therapy by data source and race/ethnicity
Table 6	HIV-infected patients currently prescribed highly active antiretroviral therapy (HAART) by data source and insurance status
Table 7	HIV-infected patients currently prescribed highly active antiretroviral therapy (HAART) by data source and sex
Table 8	HIV-infected patients currently prescribed highly active antiretroviral therapy (HAART) by data source and race/ethnicity

B. Pneumocystis carinii Pneumonia
Table 9	HIV-infected patients ever diagnosed with Pneumocystis carinii pneumonia (PCP) by data source and sex
Table 10	HIV-infected patients ever diagnosed with Pneumocystis carinii pneumonia (PCP) by data source and race/ethnicity
Table 11	HIV-infected patients currently prescribed Pneumocystis carinii pneumonia (PCP) prophylaxis by data source and insurance status
Table 12	HIV-infected patients prescribed primary Pneumocystis carinii pneumonia (PCP) prophylaxis by data source and sex
Table 13	HIV-infected patients prescribed primary Pneumocystis carinii pneumonia (PCP) prophylaxis by data source and race/ethnicity

C. Tuberculin Skin Test
Table 14	HIV-infected patients receiving a tuberculin skin test (TST) by data source and sex
Table 15	HIV-infected patients receiving a tuberculin skin test (TST) by data source and race/ethnicity